AIMS/HYPOTHESIS: Paraoxonase is a member of a multigene family of three genes. Paraoxonase2 gene polymorphisms have been associated with coronary heart disease in non-diabetic patients and with an increased fasting glycaemia in patients with Type II (non-insulin-dependent) diabetes mellitus. We tested the hypothesis of whether paraoxonase1 and paraoxonase2 polymorphisms were associated with diabetic nephropathy. METHODS: Our case-control study of 299 Swiss patients with Type II diabetes included 147 patients with confirmed diabetic nephropathy. RESULTS: In univariate analyses the two paraoxonase2 polymorphisms were associated with diabetic nephropathy. When subjected to multivariate analyses, both paraoxonase2 polymorphisms remained statistically associated with diabetic nephropathy independent of traditional risk factors (paraoxonase2-148: OR = 2.53, p = 0.003; paraoxonase2-311: OR = 2.67, p = 0.002). In addition, BMI interacted with paraoxonase2 polymorphisms as a risk factor of nephropathy. CONCLUSIONS/ INTERPRETATION: The paraoxonase2 gene polymorphisms were significantly associated with diabetic nephropathy independent of traditional risk factors in Type II diabetic patients. The susceptibility to diabetic nephropathy was intensified by the degree of obesity. Pathophysiological pathways should be investigated and could be involved in insulin resistance or lipids metabolism or both.
AIMS/HYPOTHESIS: Paraoxonase is a member of a multigene family of three genes. Paraoxonase2 gene polymorphisms have been associated with coronary heart disease in non-diabeticpatients and with an increased fasting glycaemia in patients with Type II (non-insulin-dependent) diabetes mellitus. We tested the hypothesis of whether paraoxonase1 and paraoxonase2 polymorphisms were associated with diabetic nephropathy. METHODS: Our case-control study of 299 Swiss patients with Type II diabetes included 147 patients with confirmed diabetic nephropathy. RESULTS: In univariate analyses the two paraoxonase2 polymorphisms were associated with diabetic nephropathy. When subjected to multivariate analyses, both paraoxonase2 polymorphisms remained statistically associated with diabetic nephropathy independent of traditional risk factors (paraoxonase2-148: OR = 2.53, p = 0.003; paraoxonase2-311: OR = 2.67, p = 0.002). In addition, BMI interacted with paraoxonase2 polymorphisms as a risk factor of nephropathy. CONCLUSIONS/ INTERPRETATION: The paraoxonase2 gene polymorphisms were significantly associated with diabetic nephropathy independent of traditional risk factors in Type II diabeticpatients. The susceptibility to diabetic nephropathy was intensified by the degree of obesity. Pathophysiological pathways should be investigated and could be involved in insulin resistance or lipids metabolism or both.
Authors: R Calle; M I McCarthy; P Banerjee; E Zeggini; C A Cull; K I Thorne; S Wiltshire; S Terra; D Meyer; J Richmond; J Mancuso; P Milos; D Fryburg; R R Holman Journal: Diabetologia Date: 2006-10-03 Impact factor: 10.122
Authors: Sudeshna Dasgupta; F Yesim Demirci; Amy S Dressen; Amy H Kao; Elisa Y Rhew; Rosalind Ramsey-Goldman; Susan Manzi; Candace M Kammerer; M Ilyas Kamboh Journal: BMC Med Genet Date: 2011-01-11 Impact factor: 2.103
Authors: Farook Thameem; Xin He; V Saroja Voruganti; Subrata D Nath; Paolo Fanti; John Blangero; Jean W Maccluer; Anthony G Comuzzie; Nedal H Arar; Hanna E Abboud Journal: Kidney Blood Press Res Date: 2009-06-18 Impact factor: 2.687
Authors: Vincent Dunet; Juan Ruiz; Gilles Allenbach; Paola Izzo; Richard W James; John O Prior Journal: EJNMMI Res Date: 2011-11-18 Impact factor: 3.138
Authors: David-Alexandre Trégouet; Per-Henrik Groop; Steven McGinn; Carol Forsblom; Samy Hadjadj; Michel Marre; Hans-Henrik Parving; Lise Tarnow; Ralph Telgmann; Tiphaine Godefroy; Viviane Nicaud; Rachel Rousseau; Maikki Parkkonen; Anna Hoverfält; Ivo Gut; Simon Heath; Fumihiko Matsuda; Roger Cox; Gbenga Kazeem; Martin Farrall; Dominique Gauguier; Stefan-Martin Brand-Herrmann; François Cambien; Mark Lathrop; Nathalie Vionnet Journal: Diabetes Date: 2008-07-15 Impact factor: 9.461